FLOVENT EFFICACY SUMMARY

• Significantly greater improvements in primary efficacy measure (pre-dose FEV1)

  • Magnitude of improvement related to reversibility

• Secondary efficacy measures supportive

• Suggestion of dose response

Previous slide

Next slide

Back to first slide

View graphic version